Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-26-002862·Travere Therapeutics, Inc.
Schedule 13G ownership disclosure
TRAVERE THERAPEUTICS INC
COMMON STOCK · CUSIP: 89422G107
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 5,707,883.15 · Class: 6.1%
- Abigail P. Johnson
Shares: 5,707,883.15 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-26-002862
- Form type
- SCHEDULE 13G/A
- Filer
- Travere Therapeutics, Inc.
- CIK
- CIK 1438533
- Filed
- Nov 05, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership